Bright Futures Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$276K Sell
11,469
-4,106
-26% -$107K 0.18% 150
2026
Q1
$437K Buy
15,575
+1,293
+9% +$34.4K 0.3% 93
2025
Q4
$356K Buy
14,282
+2,804
+24% +$70.7K 0.26% 98
2025
Q3
$292K Buy
+11,478
New +$283K 0.23% 104
2025
Q1
$244K Buy
11,073
+1,394
+14% +$36.5K 0.27% 97
2024
Q4
$258K Sell
9,679
-958
-9% -$26K 0.23% 101
2024
Q3
$303K Sell
10,637
-735
-6% -$21.4K 0.15% 167
2024
Q2
$346K Sell
11,372
-177
-2% -$4.87K 0.19% 137
2024
Q1
$321K Buy
+11,549
New +$320K 0.17% 145

Other funds holding PFE

Bright Futures Wealth Management's PFE Position: Q2 2026 in Review

Bright Futures Wealth Management reduced its Pfizer (PFE) stake by 26% in Q2 2026, selling an estimated $107K and leaving 11,469 shares worth $276K. The position accounts for 0.18% of the portfolio, ranked #150.

Bright Futures Wealth Management first reported a position in PFE in Q1 2024 and has held it in 9 quarters since. The position peaked at $437K in Q1 2026. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Bright Futures Wealth Management held 11,469 shares of Pfizer worth $276K as of Q2 2026.
  • Bright Futures Wealth Management sold 4,106 Pfizer shares in Q2 2026, an estimated $107K.
  • Pfizer made up 0.18% of Bright Futures Wealth Management's portfolio in Q2 2026, its #150 holding.
  • Bright Futures Wealth Management first reported a position in Pfizer in Q1 2024 and has held it in 9 quarters since.
  • Bright Futures Wealth Management's Pfizer position peaked at $437K in Q1 2026.
  • 2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Bright Futures Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.